Rheumatoid arthritis study of the Egyptian College of Rheumatology (ECR): nationwide presentation and worldwide stance
Authors:
- Tamer A. GheitaTGTamer A. Gheita
- Hala A. RaafatHRHala A. Raafat
- Samah A. El-BakrySESamah A. El-Bakry
- Ahmed ElsamanAEAhmed Elsaman
- Hanan M. El-SaadanyHEHanan M. El-Saadany
- Nevin HammamNHNevin Hammam
- Iman I. El-GazzarIEIman I. El-Gazzar
- Nermeen SamyNSNermeen Samy
- Nora Y. ElsaidNENora Y. Elsaid
- Suzan S. Al-AdleSASuzan S. Al-Adle
- Samar TharwatSTSamar Tharwat
- Amira M. IbrahimAIAmira M. Ibrahim
Open Access
- 8 January 2023
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 43 (4) , 667-676
Abstract
To depict the spectrum of rheumatoid arthritis (RA) in Egypt in relation to other universal studies to provide broad-based characteristics to this particular population. This work included 10,364 adult RA patients from 26 specialized Egyptian rheumatology centers representing 22 major cities all over the country. The demographic and clinical features as well as therapeutic data were assessed. The mean age of the patients was 44.8 ± 11.7 years, disease duration 6.4 ± 6 years, and age at onset 38.4 ± 11.6 years; 209 (2%) were juvenile-onset. They were 8750 females and 1614 males (F:M 5.4:1). 8% were diabetic and 11.5% hypertensive. Their disease activity score (DAS28) was 4.4 ± 1.4 and health assessment questionnaire (HAQ) 0.95 ± 0.64. The rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) were positive in 73.7% and 66.7% respectively. Methotrexate was the most used treatment (78%) followed by hydroxychloroquine (73.7%) and steroids (71.3%). Biologic therapy was received by 11.6% with a significantly higher frequency by males vs females (15.7% vs 10.9%, p = 0.001). The least age at onset, F:M, RF and anti-CCP positivity were present in Upper Egypt (p < 0.0001), while the highest DAS28 was reported in Canal cities and Sinai (p < 0.0001). The HAQ was significantly increased in Upper Egypt with the least disability in Canal cities and Sinai (p = 0.001). Biologic therapy intake was higher in Lower Egypt followed by the Capital (p < 0.0001). The spectrum of RA phenotype in Egypt is variable across the country with an increasing shift in the F:M ratio. The age at onset was lower than in other countries.Keywords
Funding Information
- Cairo University
This publication has 44 references indexed in Scilit:
- Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patientsPLOS ONE, 2018
- Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritisArthritis Research & Therapy, 2017
- Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registersAnnals of the Rheumatic Diseases, 2017
- Obesity Associated With Active, but Preserved Joints in Rheumatoid Arthritis: Results From our National RegistryArchives of Rheumatology, 2016
- The role of female hormonal factors in the development of rheumatoid arthritisRheumatology, 2016
- Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort StudyEBioMedicine, 2016
- Korean Observational Study Network for Arthritis (KORONA): Establishment of a Prospective Multicenter Cohort for Rheumatoid Arthritis in South KoreaSeminars in Arthritis and Rheumatism, 2012
- A Comparison of Patient Characteristics and Outcomes in Selected European and U.S. Rheumatoid Arthritis RegistriesSeminars in Arthritis and Rheumatism, 2010
- The Stanford Health Assessment Questionnaire: Dimensions and Practical ApplicationsHealth and Quality of Life Outcomes, 2003
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995